Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial - Wanner, C; Heerspink, H JL; Zinman, B (J Am Soc Nephrol, 2018)